KALY Bullish Candlestick Pattern Confirms Short Squeeze Potential With 400% To 1000% ROI Potential - Watch For Imminent Reversal
New York, NY -- July 11, 2019 -- InvestorsHub NewsWire -- via www.nextbigticker.com -- Kali-Extracts, Inc. (USOTC: KALY) was reported under a short squeeze alert yesterday and today the KALY candlestick trading pattern confirms the short squeeze potential. AmericanBulls.com has reported a BULLISH DECENT BLOCK indicating that short sellers are fighting to hold on.
AmericanBulls.com on the BULLISH DECENT BLOCK
“With three black candlesticks, it looks as though bears rule over the market; however there are signs of weaknesses. Firstly, the bodies get shorter and shorter, showing that indecision is increasing. Secondly, each day opens within the range of the previous day’s body. Thirdly, the lower shadows are getting longer. While the second and the third days are closing lower, the distance between closes are getting shorter. This means that the downtrend is losing strength and that short traders must be cautious.”
KALY 400% to 1000% ROI Potential
KALY has endured excessive short selling with well over 50% of the recent trading volume coming from short sales. FINRA has reported short selling as high as 83% of the total volume. The candlestick pattern today indicates a coming reversal is on the horizon and the short sellers having to cover from excessive short sales could drive the KALY PPS even higher. The company has announced $15 million in CBD Extraction Contracts. KALY reached almost $0.04 high late last year after acquiring the US Patented Cannabis Extraction Process that is currently the center of the company’s growing value. With KALY’s patented cannabis pharmaceutical research now coming to light in combination with the $15 million in CBD extraction contracts, the PPS is positioned to shoot past the recent $0.04 high. With a short squeeze bonus, a $0.10 PPS is not an unreasonable milestone.
In addition to the pharmaceutical research and the $15 million in CBD extraction contracts, KALY is providing CBD extracts for over $1 million worth of CBD infused water produced by Puration, Inc. (USOTC: PURA), and KALY has also introduced its own CBD infused gum, Hemp4mula available on North American Cannabis Holdings (USOTC: USMJ), Inc.’s website www.USMJ.com.
KALY Analyst Report
Management engaged Goldman Small Cap Research to conduct analyst coverage of the company and file an initial analyst report: KALY Research Report
Hemp, Inc. (HEMP) is another heavily shorted stock making impressive operational gains that stands to benefit from a potential short squeeze.
NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.